Searchable abstracts of presentations at key conferences in endocrinology

ea0012p114 | Reproduction | SFE2006

Effect of serum testosterone concentrations on outcome of induction of ovulation by low-dose FSH in women with polycystic ovary syndrome (PCOS)

Gorry Anwen , White Davinia , Franks Stephen

The recent recommendations from the joint ESHRE/ASRM expert panel regarding the definition of PCOS (the so-called Rotterdam Criteria) have given rise to considerable controversy, particularly over the inclusion of anovulatory women with polycystic ovaries (PCO) but without evidence of androgen excess. We reviewed the results of a large series of anovulatory women with PCO who have been treated with low-dose FSH at our centre with the aim of investigating the impact of serum te...

ea0011p348 | Diabetes, metabolism and cardiovascular | ECE2006

Coronary artery disease and heart failure in diabetic patients in the north of portugal

Neves C , Medina JL , Lopes F

Aims: The aim of our study was to evaluate the incidence of coronary artery disease (CAD) and heart failure (HF) in diabetic and nondiabetic patients admitted to a central hospital in the North of Portugal between 1989 and 2004.Materials and methods: Data from the Hospital Coding Centre were retrospectively analysed according to International Classification of Diseases (9th version) criteria. We have studied the distribution by age, sex, procedures, caus...

ea0011p366 | Diabetes, metabolism and cardiovascular | ECE2006

Is there male androgenetic alopecia the sign of male equivalent of polycystic ovary syndrome or metabolic syndrome?

Duskova M , Starka L , Hill M , Dolezal M , Simunkova K , Cermakova I

Introduction: Androgenetic alopecia (AGA) is the most common cause of balding in men. AGA is the risk factor of cardiovascular diseases, glucose metabolism disorders and also the risk of benign prostethyperplasia and prostate carcinoma. Polycystic ovary syndrome (PCOS) and metabolic syndrome are the risk factors of insulin resistance, obesity and diabetes mellitus. The genetic autosomal trait of PCOS initiated a hypothesis about the existence of a male equivalent of PCOS. Prem...

ea0011p867 | Thyroid | ECE2006

Cardiovascular disease in patients with and without hypothyroidism

Neves C , Medina JL , Lopes F

Aims: To evaluate the cardiovascular morbidity in patients with and without hypothyroidism admitted to a central hospital, between 1989 and 2004.Materials and methods: Data from the Hospital Coding Centre were retrospectively analysed according to International Classification of Diseases (9th version) criteria. We have studied the distribution by age, sex, causes and duration of admissions. Statistical analysis was performed with Student’s t-test, &...

ea0008oc13 | Neuroendocrinology and Reproduction | SFE2004

Reduced expression of anti-Mullerian hormone (AMH) protein in the androgenised sheep ovary

Bull L , Stubbs S , Birch R , Robinson J , Themmen AP , Visser JA , Groome NP , Hardy K , Franks S

The prenatally androgenised sheep, like the Rhesus monkey, is an informative model for polycystic ovary syndrome (PCOS). We have recently demonstrated that AMH protein is reduced in preantral follicles of PCOS ovaries (Stubbs et al, Endocrine Abstracts 2004, 7 P186 ). We hypothesized that reduced expression of AMH is an effect of androgen excess. The aim of this study was to examine AMH immunostaining in ovaries from prenatally androgen-treated and control ewes. Ovaries were t...

ea0008p75 | Reproduction | SFE2004

Evidence for a role of the Type 1 IGF receptor in early follicular development in cultured human ovarian tissue

Stubbs S , Margara R , Trew G , Lavery S , Franks S , Hardy K

Little is known about the factors affecting preantral follicle growth but we have recently shown that IGF-I stimulates growth of follicles in human cortical tissue in culture (Stubbs et al, Endocrine Abstracts 2003, 6, OC7). The aim of this study was to extend the study of the effects of IGF-I on follicle recruitment and test the specificity of action by examining the ability of the type 1 IGF receptor antibody, alpha-IR3, to inhibit IGF action. Small ovarian cortical biopsies...

ea0008go5 | (1) | SFE2004

Evidence for a role of the Type 1 IGF receptor in early follicular development in cultured human ovarian tissue

Stubbs S , Margara R , Trew G , Lavery S , Franks S , Hardy K

Little is known about the factors affecting preantral follicle growth but we have recently shown that IGF-I stimulates growth of follicles in human cortical tissue in culture (Stubbs et al, Endocrine Abstracts 2003, 6, OC7). The aim of this study was to extend the study of the effects of IGF-I on follicle recruitment and test the specificity of action by examining the ability of the type 1 IGF receptor antibody, alpha-IR3, to inhibit IGF action. Small ovarian cortical biopsies...

ea0007p99 | Endocrine tumours and neoplasia | BES2004

Factors determining remission of microprolactinomas after dopamine agonist withdrawal

Powrie J , Athauda N

It is common practice to attempt withdrawal of dopamine agonist (DA) therapy in patients with microprolactinomas who have achieved sustained normoprolactinaemia. There is, however little evidence to indicate which patients might attain long-term remission. The aim of this prospective study was to identify clinical factors that might predict such remission.We recruited 40 patients (39 females and 1 male, age 24-60 years) with a diagnosis of microprolactin...

ea0056gp68 | Cardiovascular | ECE2018

Turner syndrome and cardiovascular risk

Marques Bernardo , Bastos Margarida , Oliveira Diana , Martins Diana , Lages Adriana , Ventura Mara , Cunha Nelson , Fadiga Lucia , Catarino Diana , Carrilho Francisco

Introduction: Turner Syndrome (TS) is associated with cardiovascular anomalies and account for a threefold higher mortality in these women. The most common findings are congenital malformations of the heart (CMH), aortic dissection, valvular heart disease (VHD), hypertension and ischemic heart disease. It has been suggested that the ocurrence of cardiovascular disease in TS women is related to their karyotype and possibly to growth hormone (GH) treatment. Our study aimed to as...

ea0056gp77 | Diabetes Complications | ECE2018

Patients with community acquired pneumonia are three times more likely to die if they have concomitant diabetes mellitus

Joy Elsa , Singh Navjyot , Jacob Jubbin

Objective: To compare the clinical features, mortality and morbidity outcomes in patients with diabetes mellitus and patients without diabetes mellitus, who are hospitalized with community acquired pneumonia (CAP).Methods: This cross sectional study included 175 patients (49 patients with diabetes and 126 without diabetes) admitted with CAP to a tertiary care hospital. The study included both quantitative and qualitative variables, which were compared us...